Everspin (ESMT) stock trades at $27 despite analyst targets of $14-$18.50. Strong Q1 results and $40M defense deal fuel debate over valuation.
Author: Trader Edge
Hims & Hers (HIMS) reports Q1 earnings May 11. Analysts expect 5.2% revenue growth and 3-4 cents EPS as Novo Nordisk partnership begins.
Delivery Hero (DHER) stock climbed 7% as Prosus sold a 5% stake to Aspex Management for €335M, meeting EU antitrust conditions from Just Eat acquisition.
Micron (MU) and SK Hynix stocks climb as Samsung faces strike threat starting May 21. Labor dispute could disrupt 3% of global memory chip production.
Nintendo shares fell 8.4% following Switch 2 price hikes and lower-than-expected earnings guidance, raising concerns about console demand and profitability.
AI stocks drive 80% of S&P 500 gains in 2026. Jefferies says valuations remain attractive despite concentration, with Samsung crossing $1 trillion milestone.
Gold slipped 1% to $4,669/oz after Trump rejected Iran’s peace offer. Oil surged 5% as the Strait of Hormuz stays shut, pressuring precious metals.
IonQ (IONQ) stock gained 3.27% after SkyWater shareholders approved the merger. The transaction is expected to close in Q2 or Q3 2026 pending approvals.
ON Semiconductor (ON) stock surged 90% in 2025 on AI data center demand. Q1 beat estimates, but analysts’ $87 target trails the $103 price.
Intel (INTC) stock hit record highs after Apple chip deal news, but BofA keeps Underperform rating, warning gains are already priced in at current levels.
OpenAI employees sold $6.6 billion in shares through a pre-IPO tender offer, with 75 workers cashing out the maximum $30 million allowed per person.
Oklo reports Q1 2026 earnings May 12. Stock up 30% on NRC approval and Nvidia partnership. Analysts see 27% upside. Is OKLO stock a buy now?
CoreWeave (CRWV) stock plunged 11% after missing Q1 earnings estimates. Major insider Magnetar sold $370M in shares the same day as the report.
Bitcoin steadies near $81K after Trump rejects Iran peace talks. Stock futures decline while Senate preps crypto Clarity Act vote for May 14.
GSK partners with Sino Biopharmaceutical’s CTTQ to distribute hepatitis B treatment bepirovirsen in China, targeting 75 million patients. GSK stock rises.

